Notably, B2m expression exhibited significant attenuation in response to IFNγ for DKO cells (Fig 2D), suggesting that MBNL proteins contribute to the modulation of the tumor-immune interaction in part via alterations in expression levels of components of MHC Class I antigen presentation. The gene discussed is B2M; the disease is neoplasm.